Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Galectin-3 levels are elevated following nintedanib treatment.
Shochet GE, Pomerantz A, Shitrit D, Bardenstein-Wald B, Ask K, Surber M, Rabinowicz N, Levy Y, Benchetrit S, Edelstein E, Zitman-Gal T. Shochet GE, et al. Among authors: rabinowicz n. Ther Adv Chronic Dis. 2020 Nov 27;11:2040622320968412. doi: 10.1177/2040622320968412. eCollection 2020. Ther Adv Chronic Dis. 2020. PMID: 33708368 Free PMC article.
The Hebrew version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Uziel Y, Sherman G, Rabinowicz N, Harel L, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO). Uziel Y, et al. Among authors: rabinowicz n. Rheumatol Int. 2018 Apr;38(Suppl 1):227-233. doi: 10.1007/s00296-018-3956-x. Epub 2018 Apr 7. Rheumatol Int. 2018. PMID: 29637355 Free PMC article.
The effect of hypotensive drugs on intraocular lenses clarity.
Sharon T, Naftali Ben Haim L, Rabinowicz N, Kidron D, Kidron A, Ton Y, Einan-Lifshitz A, Assia EI, Belkin A. Sharon T, et al. Among authors: rabinowicz n. Eye (Lond). 2023 Jun;37(8):1696-1703. doi: 10.1038/s41433-022-02225-w. Epub 2022 Sep 7. Eye (Lond). 2023. PMID: 36071178 Free PMC article.
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer.
Rabinowicz N, Mangala LS, Brown KR, Checa-Rodriguez C, Castiel A, Moskovich O, Zarfati G, Trakhtenbrot L, Levy-Barda A, Jiang D, Rodriguez-Aguayo C, Pradeep S, van Praag Y, Lopez-Berestein G, David A, Novikov I, Huertas P, Rottapel R, Sood AK, Izraeli S. Rabinowicz N, et al. Oncotarget. 2017 Apr 18;8(16):27380-27392. doi: 10.18632/oncotarget.16068. Oncotarget. 2017. PMID: 28423708 Free PMC article.
15 results